Arrowstreet Capital, Limited Partnership Idexx Laboratories Inc Transaction History

Arrowstreet Capital, Limited Partnership

$108 Billion
Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 172,577 shares of IDXX stock, worth $84.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

172,577

Previous 175,173 1.48%

Holding current value

$84.1 Million

Previous $97.2 Million 4.17%

% of portfolio

0.09%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$515.08 - $576.87 $1.34 Million - $1.5 Million	-2,596 Reduced 1.48%	172,577 $93.2 Million
Q4 2023 Feb 14, 2024	BUY	$391.37 - $557.56 $262,609 - $374,122	671 Added 0.38%	175,173 $97.2 Million
Q3 2023 Nov 14, 2023	SELL	$432.42 - $556.67 $26.1 Million - $33.6 Million	-60,386 Reduced 25.71%	174,502 $76.3 Million
Q2 2023 Aug 14, 2023	SELL	$450.7 - $503.61 $7.72 Million - $8.63 Million	-17,140 Reduced 6.8%	234,888 $118 Million
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $6.76 Million - $8.57 Million	-16,660 Reduced 6.2%	252,028 $126 Million

Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $1.81 Million - $2.46 Million	5,576 Added 2.12%	268,688 $110 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $42.3 Million - $52.9 Million	-129,683 Reduced 33.02%	263,112 $85.7 Million
Q2 2022 Aug 15, 2022	SELL	$327.37 - $553.44 $8.61 Million - $14.5 Million	-26,290 Reduced 6.27%	392,795 $138 Million
Q1 2022 May 13, 2022	SELL	$466.52 - $631.01 $42.2 Million - $57 Million	-90,404 Reduced 17.74%	419,085 $229 Million
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $20.8 Million - $23.6 Million	35,435 Added 7.47%	509,489 $335 Million
Q3 2021 Nov 12, 2021	BUY	$621.9 - $705.76 $122 Million - $139 Million	196,377 Added 70.72%	474,054 $295 Million
Q2 2021 Aug 13, 2021	BUY	$486.36 - $637.08 $78.3 Million - $103 Million	160,922 Added 137.83%	277,677 $175 Million
Q1 2021 May 14, 2021	BUY	$465.18 - $551.79 $52.5 Million - $62.3 Million	112,955 Added 2972.5%	116,755 $57.1 Million
Q4 2020 Feb 12, 2021	BUY	$383.85 - $499.87 $1.04 Million - $1.35 Million	2,700 Added 245.45%	3,800 $1.9 Million
Q3 2020 Nov 12, 2020	SELL	$334.54 - $406.31 $16.2 Million - $19.6 Million	-48,322 Reduced 97.77%	1,100 $432,000
Q2 2020 Aug 12, 2020	SELL	$230.66 - $330.16 $16.9 Million - $24.1 Million	-73,063 Reduced 59.65%	49,422 $16.3 Million
Q1 2020 May 15, 2020	BUY	$182.94 - $290.97 $8.41 Million - $13.4 Million	45,966 Added 60.07%	122,485 $29.7 Million
Q4 2019 Feb 13, 2020	BUY	$248.66 - $285.01 $19 Million - $21.8 Million	76,519 New	76,519 $20 Million
Q3 2019 Nov 14, 2019	SELL	$260.07 - $289.93 $11 Million - $12.2 Million	-42,247 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$215.53 - $275.33 $58.3 Million - $74.5 Million	-270,569 Reduced 86.49%	42,247 $11.6 Million
Q1 2019 May 15, 2019	SELL	$178.02 - $225.69 $31.1 Million - $39.4 Million	-174,505 Reduced 35.81%	312,816 $69.9 Million
Q4 2018 Feb 14, 2019	SELL	$176.18 - $248.92 $83.7 Million - $118 Million	-475,235 Reduced 49.37%	487,321 $90.7 Million
Q3 2018 Nov 14, 2018	SELL	$218.82 - $254.46 $10.2 Million - $11.9 Million	-46,777 Reduced 4.63%	962,556 $240 Million
Q2 2018 Aug 14, 2018	SELL	$185.56 - $227.9 $12.2 Million - $15 Million	-65,656 Reduced 6.11%	1,009,333 $220 Million
Q1 2018 May 14, 2018	SELL	$157.81 - $204.73 $28.3 Million - $36.7 Million	-179,424 Reduced 14.3%	1,074,989 $206 Million
Q4 2017 Feb 09, 2018	SELL	$147.68 - $168.37 $8.42 Million - $9.61 Million	-57,047 Reduced 4.35%	1,254,413 $196 Million
Q3 2017 Nov 14, 2017	BUY	$150.32 - $166.46 $197 Million - $218 Million	1,311,460	1,311,460 $204 Million

Others Institutions Holding IDXX

# of Institutions

1,212

Shares Held

71.7M

Call Options Held

168K

Put Options Held

394K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $40.6B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Idexx Laboratories Inc Transaction History